PozNews - HIV News - STD News: GeoVax Labs Granted Allowance By FDA To Start Phase 1 Clinical Trial For HIV/AIDS Therapeutic Vaccine

GeoVax Labs Granted Allowance By FDA To Start Phase 1 Clinical Trial For
HIV/AIDS Therapeutic Vaccine
================================================================================
Medical News Today on 31 March, 2010 12:00:00
 
GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), a biotechnology company that
creates, develops, and tests innovative HIV/AIDS vaccines, is now allowed by the
FDA (US Food and Drug Administration) to begin a phase 1 clinical trial for
GeoVax's therapeutic vaccine, which is intended as a treatment for individuals
infected with HIV (Human Immunodeficiency Virus)...